The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2006

Filed:

Jun. 15, 2001
Applicants:

Srinivasan Raj Nagarajan, Chesterfield, MO (US);

Ish Kumar Khanna, Libertyville, IL (US);

Michael B. Tollefson, Hainesville, IL (US);

Scott B. Mohler, Chicago, IL (US);

Barbara B. Chen, Glenview, IL (US);

Mark Russell, Gurnee, IL (US);

Balekudru Devadas, Chesterfield, MO (US);

Thomas D. Penning, Elmhurst, IL (US);

Lori A. Schretzman, Gurnee, IL (US);

Dale P. Spangler, Deerfield, IL (US);

Mark L. Boys, Mount Prospect, IL (US);

Nizal S. Chandrakumar, Vernon Hills, IL (US);

Hwang-fun LU, Manchester, MO (US);

Inventors:

Srinivasan Raj Nagarajan, Chesterfield, MO (US);

Ish Kumar Khanna, Libertyville, IL (US);

Michael B. Tollefson, Hainesville, IL (US);

Scott B. Mohler, Chicago, IL (US);

Barbara B. Chen, Glenview, IL (US);

Mark Russell, Gurnee, IL (US);

Balekudru Devadas, Chesterfield, MO (US);

Thomas D. Penning, Elmhurst, IL (US);

Lori A. Schretzman, Gurnee, IL (US);

Dale P. Spangler, Deerfield, IL (US);

Mark L. Boys, Mount Prospect, IL (US);

Nizal S. Chandrakumar, Vernon Hills, IL (US);

Hwang-Fun Lu, Manchester, MO (US);

Assignee:

Pharmacia Corporation, Chesterfield, MO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 401/12 (2006.01); A61K 31/443 (2006.01); A61K 31/4375 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a class of compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of Formula (I), and methods of selectively antagonizing the ανβand/or the ανβintegrin without significantly antagonizing the IIb/IIIa integrin.


Find Patent Forward Citations

Loading…